Evaluation of Reversed Administration Order of Busulfan (BU) and Cyclophosphamide (CY) as Conditioning on Liver Toxicity in Allogenic Hematopoietic Stem Cell Transplantation (ALL-HSCT)

Background: Busulfan (BU) in combination with cyclophosphamide (CY) is used as an effective conditioning regimen in hematopoietic SCT. Busulfan, depletes glutathione level in liver and causes elevated levels of CY metabolites. Cyclophosphamide metabolites are highly toxic for sinusoidal endothelial...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramzi, Mani, Namdari, Nasrin, Haghighat, Shirin, Haghighinejad, Hourvash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521389/
https://www.ncbi.nlm.nih.gov/pubmed/33024523
http://dx.doi.org/10.18502/ijhoscr.v14i3.3725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521389/
https://www.ncbi.nlm.nih.gov/pubmed/33024523
http://dx.doi.org/10.18502/ijhoscr.v14i3.3725

Ejemplares similares